CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TARSUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,347,761
+21.4%
188,394
+23.4%
0.00%0.0%
Q2 2023$2,758,638
+57.7%
152,664
+9.7%
0.00%0.0%
Q1 2023$1,749,128
-13.9%
139,151
+0.4%
0.00%0.0%
Q4 2022$2,031,158
-13.0%
138,551
+1.6%
0.00%0.0%
Q3 2022$2,335,000
+72.5%
136,380
+47.1%
0.00%
Q2 2022$1,354,000
+65.5%
92,733
+90.9%
0.00%
Q1 2022$818,000
-23.0%
48,583
+3.0%
0.00%
Q4 2021$1,062,000
+5.4%
47,181
+0.9%
0.00%
Q3 2021$1,008,000
-25.3%
46,766
+0.4%
0.00%
Q2 2021$1,350,000
+0.6%
46,573
+11.9%
0.00%
Q1 2021$1,342,000
-12.8%
41,623
+11.8%
0.00%
-100.0%
Q4 2020$1,539,00037,2230.00%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,140,586$38,038,2135.37%
Vivo Capital, LLC 2,262,200$40,199,2944.40%
TCG Crossover Management, LLC 1,142,857$20,308,5692.99%
Cormorant Asset Management, LP 2,621,422$46,582,6692.72%
Ghost Tree Capital, LLC 400,000$7,108,0002.34%
COWEN AND COMPANY, LLC 1,796,773$31,928,6562.23%
Frazier Life Sciences Management, L.P. 1,787,527$31,764,3552.11%
TFG Asset Management GP Ltd 615,000$10,928,5501.99%
Sands Capital Ventures, LLC 260,000$4,620,2001.37%
Ikarian Capital, LLC 518,519$9,214,0831.11%
View complete list of TARSUS PHARMACEUTICALS INC shareholders